Yangyan Cui
Impact in
-
- Cancer-related molecular mechanisms research
- MicroRNA in disease regulation
- Cancer, Hypoxia, and Metabolism
-
- RNA modifications and cancer
- Circular RNAs in diseases
- Epigenetics and DNA Methylation
- RNA Research and Splicing
Papers in
-
- Epigenetics and DNA Methylation 3
- Histone Deacetylase Inhibitors Research 1
- Surgery 4
- Bladder and Urothelial Cancer Treatments 3
- Co-authors
- Ruimin Huang (8 shared papers)Jun Yan (7 shared papers)Hongqian Guo (5 shared papers)Xiaojing Huang (4 shared papers)Xiaozhi Zhao (2 shared papers)Junlong Zhuang (3 shared papers)Dianzheng Zhang (3 shared papers)Lan Shen (2 shared papers)
- Journals
- Theranostics (3 papers)Frontiers in Oncology (1 paper)Frontiers in Molecular Biosciences (1 paper)Integrative Cancer Therapies (1 paper)Journal of Biological Chemistry (1 paper)
- Partner nations
- ChinaUnited States
In The Last Decade
Yangyan Cui
9 papers receiving 303 citations
Peers
Comparison fields: 5 of 47
- Cancer Research 157
- Molecular Biology 214
- Rehabilitation 20
- Applied Microbiology and Biotechnology 4
- Oncology 49
Countries citing papers authored by Yangyan Cui
This map shows the geographic impact of Yangyan Cui's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Yangyan Cui with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Yangyan Cui more than expected).
Fields of papers citing papers by Yangyan Cui
This network shows the impact of papers produced by Yangyan Cui. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Yangyan Cui. The network helps show where Yangyan Cui may publish in the future.
Co-authors
The 25 scholars most cited alongside Yangyan Cui, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2017 | 125 | |
| 2 | 2017 | 49 | |
| 3 | 2014 | 48 | |
| 4 | 2015 | 39 | |
| 5 | 2020 | 23 | |
| 6 | 2013 | 12 | |
| 7 | 2024 | 7 | |
| 8 | 2022 | 1 | |
| 9 | 2015 | 1 |
About Yangyan Cui
Yangyan Cui is a scholar working on Molecular Biology, Surgery, Cancer Research, Organic Chemistry and Rehabilitation, having authored 9 papers that have together received 305 indexed citations. Recurring topics across this work include Bladder and Urothelial Cancer Treatments (3 papers), Epigenetics and DNA Methylation (3 papers), Oxidative Organic Chemistry Reactions (2 papers), Cancer, Hypoxia, and Metabolism (2 papers), Magnolia and Illicium research (2 papers), MicroRNA in disease regulation (1 paper), Natural Compounds in Disease Treatment (1 paper) and Histone Deacetylase Inhibitors Research (1 paper). The work is most often cited by research in Cancer Research (157 citations), Molecular Biology (214 citations), Rehabilitation (20 citations), Applied Microbiology and Biotechnology (4 citations) and Oncology (49 citations). Yangyan Cui has collaborated with scholars based in China and United States. Frequent co-authors include Ruimin Huang, Jun Yan, Hongqian Guo, Xiaojing Huang, Xiaozhi Zhao, Junlong Zhuang, Dianzheng Zhang, Lan Shen, Qun Lu and Lin Yang. Their work appears in journals such as Theranostics, Frontiers in Oncology, Frontiers in Molecular Biosciences, Integrative Cancer Therapies and Journal of Biological Chemistry.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.